There Are Other Dimensions Of Biotechnology. If

One Reason There Are So Many Short-lived Management Fads Is That Their Prescriptions Were Derived And Advocated In Precisely This Way. So Managers Read About A Fad And Try It, Find That It Doesn't Work, Abandon The Effort, And Move On To The Next Thing. In Reality, It Is Usually The Case That The Faddish Prescription Was Indeed Sound Advice In Certain Circumstances, But Actually Was Poor Advice In Other Circumstances.

This Is One Of The Innovator’s Dilemmas: Blindly Following The Maxim That Good Managers Should Keep Close To Their Customers Can Sometimes Be A Fatal Mistake.

Often They [writers On The Study Of Management] Have A Point Of View Based Upon Intuition And Experience. They Then Offer A Cadence Of Two-paragraph Examples Carefully Selected To "prove" Their Theory, And Then They Write "one Size Fits All" Books. The Message Is, "if You'd Do What These Companies Did, You'd Be Successful Too."

Regulatory Fiat Cannot Create A Market At A Technologically Interdependent Interface. And By The Same Token, Regulation And So-called Monopoly Power Rarely Prevail At Modular Interfaces Between Stages Of Value-added Technology.

You Can't Find Returns In Investments You Haven't Made.